80nm NHS-Activated Silver Nanoparticle Conjugation Kit (MIDI Scale-Up Kit)

When nanoparticle conjugation, protein labeling, and assay development require a defined workflow component, the 80 nm NHS-activated silver nanoparticle conjugation MIDI scale-up kit format helps procurement and lab teams identify the relevant kit chemistry and use case.

This NHS-activated silver nanoparticle conjugation kit is intended for covalent coupling of primary amine-containing proteins or ligands. It supports protein labeling and assay development workflows where a pre-activated nanoparticle surface is preferred over manual activation.

Choose the 80 nm particle size according to the optical response, surface area and assay format required by the experiment. The MIDI scale-up version is positioned for larger-scale conjugate preparation after a workflow has been established. If early optimization is still needed, compare it with the matching optimization or size-panel products.

NHS ester activation is used for covalent coupling to primary amine-containing proteins or ligands. This chemistry is relevant for protein labeling, antibody-related assay development and workflows where a pre-activated nanoparticle surface is preferred over passive adsorption.

The source description frames this item around conjugation workflow optimization. Exact reagent quantities and procedural details should remain in the product specifications, while this description explains the selection logic for the kit.

The application profile includes nanoparticle conjugation, protein labeling, and assay development. These terms reflect the supported scientific workflows for this listing and help scientists compare related products by use case, not by material alone.

For procurement teams, the MIDI scale-up designation helps distinguish this row from smaller kit formats with the same chemistry and particle size. Select it when the workflow has moved beyond first-pass conjugation testing.

For procurement and product selection, compare it with related nanoparticles by particle size, surface chemistry, formulation and listed application rather than treating all nanoparticles as interchangeable.

Workflow use cases

• Nanoparticle conjugation with supported proteins, ligands or biomolecules
• Protein labeling and protein-nanoparticle conjugate preparation
• Assay development and comparison of nanoparticle size or surface chemistry